Brain Recepter Imaging(No.2): Radiopharmaceuticals for SPECT.
نویسندگان
چکیده
منابع مشابه
Procedure guideline for brain perfusion SPECT using (99m)Tc radiopharmaceuticals 3.0.
1William Beaumont Hospital, Royal Oak, Michigan; 2Cedars Sinai Medical Center, Los Angeles California; 3University of Texas Southwestern Medical Center, Dallas Texas; 4College of Physicians and Surgeons of Columbia University, Harlem Hospital Affiliation, New York, New York; 5Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; 6Columbia-Presbyterian Medical Center, New York, ...
متن کاملNew SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
Nuclear cardiology has experienced exponential growth within the past four decades with converging capacity to diagnose and influence management of a variety of cardiovascular diseases. Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) with technetium-99m radiotracers or thallium-201 has dominated the field; however new hardware and software designs that opti...
متن کاملExendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
UNLABELLED Strong overexpression of glucagonlike peptide-1 (GLP-1) receptors in human insulinoma provides an attractive target for imaging. The first clinical trials demonstrated that GLP-1 receptor SPECT/CT using [Lys(40)(Ahx [6-aminohexanoic acid]-DOTA-(111)In)NH(2)]-exendin-4 can localize hardly detectable insulinomas. However, [Lys(40)(Ahx-DOTA-(111)In)NH(2)]-exendin-4 imaging has drawbacks...
متن کاملPET radiopharmaceuticals for probing enzymes in the brain.
Biologically important processes in normal brain function and brain disease involve the action of various protein-based receptors, ion channels, transporters and enzymes. The ability to interrogate the location, abundance and activity of these entities in vivo using non-invasive molecular imaging can provide unprecedented information about the spatio-temporal dynamics of brain function. Indeed,...
متن کاملRadiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
Nuclear medicine is returning to its origin by studying more and more metabolic signals using new positron or single-photon-emitting radiopharmaceuticals. The history of nuclear medicine over the past 50 years highlights the strong link between investments in chemistry and the development of radionuclides and radiolabeled compounds. In fact, one can trace the major advances in nuclear medicine ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: RADIOISOTOPES
سال: 1995
ISSN: 1884-4111,0033-8303
DOI: 10.3769/radioisotopes.44.12_937